Scientists at the Institute for Research in Biomedicine (IRB Barcelona) at PCB, and the KTH Royal Institute of Technology in Stockholm develop a new method that predicts the way in which proteins move to exert their biological functions. They have demonstrated that protein movement is governed by the general shape of these molecules, thereby providing new data on how proteins work—a key step for drug development.

Proteins are large molecules that carry out all basic cell functions. In order to achieve this, they continually change shape by expanding or contracting parts; they hide surfaces or reveal them to interaction with other molecules. However, these changes are very difficult to observe and the methods used by scientists to study them involve costly simulations performed in supercomputers. The results of the study published in Nature Communications now allow the development of a much simpler method that permits equally precise predictions and can be done on a standard pc. 

The changes in protein shape occur extremely fast and are almost unperceivable. “Unless you “photograph” the changes that a protein undergoes and understand its movement and therefore the underlying molecular mechanism, this process is a mystery,” explains Laura Orellana, first author of the article.  Until now, to overcome the experimental difficulties behind “photographing”proteins, scientists used theoretical models to simulate protein movements, atom by atom. “Given that proteins generally hold thousands of atoms, the calculations are lengthy and costly, and they call for the use of supercomputers for weeks and even months.”

To overcome this issue, Orellana and her colleagues used several low resolution proteins models called coarse-grained models, which greatly simplify the structure of a protein. “It is like an impressionist painting, in which you can appreciate the general picture but without many details. Using these models, we get a global view of the entire molecule and they also allow us to study changes in large proteins using a laptop in only a few minutes,” explains Orellana. “There is a huge saving in resources.”

Called eBDIMS, this novel simulation technique was developed by Orellana during her doctoral thesis under Modesto Orozco, head of the Molecular Modelling and Bioinformatics Lab at IRB Barcelona, and pioneer in coarse-grained simulations in Spain. Now, during her postdoctoral training in Erik Lindahls lab at the KHT Royal Institute of Technology in Stockholm, Orellana has perfected and tested the algorithm through a novel analysis in order to test its validity. 

A més d’una major comprensió sobre la dinàmica de proteïnes, l’estudi ofereix un gran potencial per al desenvolupament de nous fàrmacs que es troben fora de l’abast de les tècniques actuals. “La nostra validació, per si mateixa, ja ha generat noves dades sobre una proteïna que es fa servir per estudiar la transmissió neuronal. Estic segura que eBDIMS serà capaç de generar noves hipòtesis a partir d’estructures ja conegudes i obrirà les portes a tota una nova generació de dianes terapèutiques.”

In addition to shedding light on protein dynamics, the study has potential applications for the development of new drugs that cannot be addressed using current techniques. “Our validation alone has already produced new data on a protein used to study neuronal transmission. I am sure that, on the basis of known structures, eBDIMS will be able to generate new hypotheses and will pave the way to a new generation of therapeutic targets.”

The study was undertaken with the support of the Swedish Research Council, the Swedish eScience Research Center, the Ministry of Economy and Competitiveness (MINECO), the Generalitat de Catalunya, the European programme Horizon2020 and the European Research Council.

• Reference article:

Orellana, L. et al. “Prediction and validation of protein intermediate states from structurally rich ensembles and coarse-grained simulations”. Nat. Commun. 7:12575 Doi:10.1038/ncomms12575 (2016)